On April 9, Indian equity benchmarks, the Sensex and Nifty, are anticipated to open lower, influenced by mixed signals from global markets. The early optimism surrounding a US-Iran ceasefire has waned, with concerns about potential violations affecting investor sentiment. As of 07:30 AM, GIFT Nifty Futures were down 105 points or 0.44%, trading at 23,994 points. Asian markets also reflected this downward trend, with South Korea's KOSPI falling 1.43%, Japan's Nikkei 225 down 0.71%, and Hong Kong's Hang Seng declining 0.88%. In contrast, US markets closed higher, with the S&P 500 rising 2.51%. Key stocks to monitor include Tata Consultancy Services (TCS), which is set to announce quarterly earnings, and Info Edge, which reported standalone billings of ₹1,057.1 crore for Q3FY26, up from ₹983.8 crore a year ago. Additionally, Lupin received approval from the US Food and Drug Administration (FDA) for its new drug application for Dapagliflozin and Metformin Hydrochloride tablets. NHPC's Cabinet Committee on Economic Affairs has approved an investment of ₹26,069.50 crore for the Kamala Hydro Electric Project in Arunachal Pradesh, expected to generate around 6,870 million units annually. Other notable mentions include ITC Hotels, where GQG Partners sold shares worth about ₹197 crore.